南新制药
(688189)
| 流通市值：24.09亿 | | | 总市值：24.09亿 |
| 流通股本：2.74亿 | | | 总股本：2.74亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 427,810,114.4 | 439,384,715.69 | 550,365,903.94 | 490,270,275.37 |
| 应收票据及应收账款 | 63,070,155.89 | 79,246,358.7 | 112,999,233.88 | 196,319,324.59 |
| 其中：应收票据 | 483,448 | 1,434,788 | 376,650 | 721,754.4 |
| 应收账款 | 62,586,707.89 | 77,811,570.7 | 112,622,583.88 | 195,597,570.19 |
| 应收款项融资 | 8,219,717.55 | 921,367.69 | 7,291,255.42 | 3,581,332 |
| 预付款项 | 8,360,652.99 | 7,633,287.85 | 15,638,474.98 | 9,690,467.49 |
| 其他应收款合计 | 2,053,045.02 | 2,659,791.01 | 2,024,999.34 | 1,088,388.01 |
| 其中:应收利息 | - | 770,250 | - | - |
| 存货 | 47,548,168.68 | 55,636,697.39 | 54,225,122.03 | 61,166,785.39 |
| 其他流动资产 | 16,852,837.1 | 16,943,090.76 | 16,345,732.3 | 16,233,089.43 |
| 流动资产合计 | 573,914,691.63 | 602,425,309.09 | 758,890,721.89 | 778,349,662.28 |
| 非流动资产: | | | | |
| 固定资产 | 149,879,516.84 | 154,894,165.41 | 160,055,330.82 | 163,557,095.29 |
| 在建工程 | 5,525,266.65 | 2,463,255.51 | 372,188.67 | 353,320.75 |
| 使用权资产 | - | - | 187,867.46 | 387,350.15 |
| 无形资产 | 130,894,665.77 | 134,974,019.3 | 139,053,372.84 | 143,134,999.08 |
| 开发支出 | 106,823,945.22 | 106,823,945.22 | 91,830,077.28 | 77,368,756.53 |
| 长期待摊费用 | 105,998.69 | 111,434.51 | 464,526.86 | 130,459.9 |
| 递延所得税资产 | 51,144,346.2 | 51,190,114.43 | 51,078,733.18 | 51,165,836.25 |
| 其他非流动资产 | 15,600,000 | 16,742,500 | 10,205,506.93 | 7,991,010 |
| 非流动资产合计 | 459,973,739.37 | 467,199,434.38 | 453,247,604.04 | 444,088,827.95 |
| 资产总计 | 1,033,888,431 | 1,069,624,743.47 | 1,212,138,325.93 | 1,222,438,490.23 |
| 流动负债: | | | | |
| 短期借款 | 148,199,491.66 | 148,166,825 | 219,044,141.67 | 218,186,641.67 |
| 应付票据及应付账款 | 16,754,249.4 | 15,756,452.79 | 28,705,587.55 | 39,590,610.58 |
| 应付账款 | 16,754,249.4 | 15,756,452.79 | 28,705,587.55 | 39,590,610.58 |
| 合同负债 | 2,201,713.49 | 2,638,563.1 | 7,617,760.94 | 1,717,411.28 |
| 应付职工薪酬 | 10,451,662.87 | 11,700,779.75 | 10,141,365.4 | 10,699,517.23 |
| 应交税费 | 1,450,079.21 | 1,602,635.16 | 1,845,091.51 | 1,262,383.41 |
| 其他应付款合计 | 40,350,677.36 | 41,754,834.32 | 59,079,155.73 | 57,393,552.17 |
| 一年内到期的非流动负债 | - | - | - | 708,264.95 |
| 其他流动负债 | 10,251,016.12 | 11,696,742.76 | 10,833,369.72 | 10,294,252.69 |
| 流动负债合计 | 229,658,890.11 | 233,316,832.88 | 337,266,472.52 | 339,852,633.98 |
| 非流动负债: | | | | |
| 租赁负债 | - | - | 743,173.65 | 228,071.82 |
| 递延收益 | 2,775,000 | 2,850,000 | 2,925,000 | 3,000,000 |
| 递延所得税负债 | 894,122.44 | 946,717.87 | 999,313.31 | 1,051,908.75 |
| 非流动负债合计 | 3,669,122.44 | 3,796,717.87 | 4,667,486.96 | 4,279,980.57 |
| 负债合计 | 233,328,012.55 | 237,113,550.75 | 341,933,959.48 | 344,132,614.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 274,400,000 | 274,400,000 | 274,400,000 | 274,400,000 |
| 资本公积 | 1,175,415,514.58 | 1,175,415,514.58 | 1,175,415,514.58 | 1,175,415,514.58 |
| 减:库存股 | 11,968,285.89 | 11,968,285.89 | 10,000,118.23 | 10,000,118.23 |
| 盈余公积 | 20,100,414.53 | 20,100,414.53 | 20,100,414.53 | 20,100,414.53 |
| 未分配利润 | -591,957,497.26 | -563,326,005.75 | -531,351,997.27 | -523,323,689.01 |
| 归属于母公司股东权益合计 | 865,990,145.96 | 894,621,637.47 | 928,563,813.61 | 936,592,121.87 |
| 少数股东权益 | -65,429,727.51 | -62,110,444.75 | -58,359,447.16 | -58,286,246.19 |
| 股东权益合计 | 800,560,418.45 | 832,511,192.72 | 870,204,366.45 | 878,305,875.68 |
| 负债和股东权益合计 | 1,033,888,431 | 1,069,624,743.47 | 1,212,138,325.93 | 1,222,438,490.23 |
| 公告日期 | 2025-10-31 | 2025-08-29 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |